A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin
Titel:
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin
Auteur:
Ranson, M. Shaw, H. Wolf, J. Hamilton, M. McCarthy, S. Dean, E. Reid, A. Judson, I.